An autopsy case of troglitazone-induced fulminant hepatitis

Diabetes Care

Volumn 21, Issue 12, 1998, Pages 2140-2143

  Shibuya, Akitaka ^a   Watanabe, Masaaki ^a   Fujita, Yoshikuni ^a   Saigenji, Katsunori ^a   Kuwao, Sadahito ^a   Takahashi, Hisao ^b   Takeuchi, Haruo ^c  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sagamichuo Clinic

^c Sagamino Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; GLIBENCLAMIDE; TROGLITAZONE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CELL INFILTRATION; CHOLESTASIS; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG SAFETY; HEPATITIS; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; LIVER FUNCTION TEST; LIVER INJURY; LIVER NECROSIS; LYMPHOCYTE ACTIVATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0031738012     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.12.2140     Document Type: Article

References (12)

1. Shibata H, Arai S, Kobayashi M, Izumi T, Maeda E, Sasahara K, Yamaguchi K, Monta A, Nishiwaki A: Phase I study of a new hypoglycemic agent CS-045 in healthy volunteers (in Japanese). Rinsho Iyaku 9:1519-1537, 1993
2. Iwamoto Y, Kuzuya T, Matsuda A, Awata T, Kumakura S, Inooka G, Shiraishi I: Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care 14:1083-1086, 1991
3. Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM: Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 15:193-203, 1992
4. Mimura K, Umeda F, Hiramatsu S, Taniguchi S, Ono Y, Nakashima N, Kobayashi K, Masakado M, Sako Y, Nawata H: Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes. Diabet Med 11:685-691, 1994
5. Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T: Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care 19:151-156, 1996
6. Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T: Clinical evaluation of a new oral hypoglycemic drug CS-045 in patients with non-insulin-dependent diabetes mellitus poorly controlled by diet alone: a double-blind, placebo-controlled study (in Japanese). Rinsho Iyaku 9:61-93, 1993
7. Akanuma Y, Kosaka K, Kuzuya T, Shigeta Y, Kaneko T: Long-term study of a new oral hypoglycemic agent CS-045 in patients with non-insulin dependent diabetes mellitus (in Japanese). Rinsho Iyaku 9:127-149, 1993
8. Watkins P, Whitcomb R: Hepatic dysfunction associated with troglitazone. N Engl J Med 338:916-917, 1997
9. Lee WM: Drug-induced hepatotoxicity. N Engl J Med 333:1118-1127, 1995
10. Paronetto F, Popper H: Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med 283:277-280, 1970
11. Houwerzijl J, DeGast G, Nater J, Esselink M, Nieweg H: Lymphocyte Stimulation tests and patch tests in carbamazepine hypersensitivity. Clin Exp Immunol 29:272-277, 1977
12. Maria V, Pinto L, Victorino R: Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis. J Hepatol 21:151-158, 1994